Physician profile
Lisa Johnson
NPI 1255776969
$2,166.81
in general payments reported to CMS, 2019-2025
14 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $549 · 2023: $531 · 2024: $643 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $510.04 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $380.14 | 2022-2024 | Breztri, Lokelma |
| Novo Nordisk INC | $252.59 | 2024-2025 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $225.00 | 2022-2023 | Arexvy |
| Astellas Pharma US INC | $125.00 | 2025 | Veozah |
| Genzyme Corporation | $106.11 | 2022 | |
| Phathom Pharmaceuticals, INC. | $102.26 | 2024-2025 | Voquezna |
| Neurocrine Biosciences, INC. | $96.00 | 2023 | Ingrezza |
| Biohaven Pharmaceuticals, INC. | $90.67 | 2021 | |
| Access Vascular INC | $86.60 | 2022 | |
| Becton, Dickinson and Company | $82.68 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.32 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.56 | 2023 | Jardiance |
| Dexcom, INC. | $13.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.